| RS1560264167 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1560264293 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1560264395 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1560264452 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1560264973 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1560265435 |
ECM1
|
Health Risk |
Pathogenic |
Lipid proteinosis, Lipid proteinosis |
| RS1560266014 |
ECM1
|
Health Risk |
Pathogenic |
— |
| RS1560267428 |
ECM1
|
Health Risk |
Pathogenic |
Lipid proteinosis, Lipid proteinosis |
| RS1560274093 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560274243 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS1560274283 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS1560277554 |
TP63
|
Health Risk |
Pathogenic |
Orofacial cleft 8, Orofacial cleft 8 |
| RS1560283028 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1560289791 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1560301690 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS1560302636 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1560303919 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560304529 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1560310917 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS1560311010 |
TP63
|
Health Risk |
Pathogenic |
Premature ovarian insufficiency, Premature ovarian failure 21 |
| RS1560311554 |
TP63
|
Health Risk |
Likely pathogenic |
Limb-mammary syndrome, Limb-mammary syndrome |
| RS1560313832 |
PIGG
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1560315890 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560323242 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560327427 |
OPA1;OPA1-AS1
|
Health Risk |
Pathogenic |
Optic atrophy, Autosomal dominant optic atrophy classic form |
| RS1560329339 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560330387 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1560336118 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS1560336134 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS1560340266 |
EVC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560340993 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560347618 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS1560348513 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS1560365123 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1560377736 |
OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant optic atrophy classic form, Inborn genetic diseases |
| RS1560380226 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS1560383746 |
TMEM165
|
Health Risk |
Likely pathogenic |
— |
| RS1560392160 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1560394912 |
PIGG
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1560395607 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560398348 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560408865 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Optic atrophy |
| RS1560414254 |
DOCK3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with impaired intellectual development, hypotonia |
| RS1560414379 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1560414398 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1560417385 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417396 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417427 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417438 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417535 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417642 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417666 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417673 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560417758 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1560418164 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1560418178 |
KIT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Piebaldism |
| RS1560418384 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1560419312 |
KIT
|
Health Risk |
Likely pathogenic |
Piebaldism, Piebaldism |
| RS1560419631 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 6, Type 2 diabetes mellitus |
| RS1560419651 |
WFS1
|
Health Risk |
Likely risk allele |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1560420761 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1560421124 |
WFS1
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Wolfram syndrome 1, Wolfram-like syndrome |
| RS1560421457 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 41, Autosomal dominant nonsyndromic hearing loss 6 |
| RS1560422046 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1560422132 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1560422383 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolfram syndrome 1, Cataract 41 |
| RS1560425213 |
CEP135
|
Health Risk |
Pathogenic |
— |
| RS1560425301 |
CEP135
|
Health Risk |
Likely pathogenic |
Microcephaly 8, primary |
| RS1560425399 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1560433104 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1560449207 |
PROM1
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS1560465524 |
PHOX2B
|
Health Risk |
Pathogenic |
— |
| RS1560465785 |
PHOX2B
|
Health Risk |
Likely pathogenic |
Aganglionic megacolon, Aganglionic megacolon |
| RS1560466246 |
PHOX2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital central hypoventilation, Congenital central hypoventilation |
| RS1560477489 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta type 2, DSPP-related disorder |
| RS1560478758 |
DSPP
|
Health Risk |
Pathogenic |
Pulp calcification, Pulp calcification |
| RS1560480632 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS1560492942 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1560499498 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1560500587 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1560501974 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560513651 |
TTN
|
Health Risk |
Pathogenic |
Congenital titinopathy, Early-onset myopathy with fatal cardiomyopathy |
| RS1560529237 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Early-onset myopathy with fatal cardiomyopathy |
| RS1560530550 |
SP110
|
Health Risk |
Pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS1560531755 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1560532624 |
PROM1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 41, Retinitis pigmentosa 41 |
| RS1560541088 |
WDR19
|
Health Risk |
Likely pathogenic |
— |
| RS1560542180 |
SMARCAD1
|
Health Risk |
Pathogenic |
Keratoderma with scleroatrophy of the extremities, Keratoderma with scleroatrophy of the extremities |
| RS1560542214 |
SMARCAD1
|
Health Risk |
Likely pathogenic |
Keratoderma with scleroatrophy of the extremities, Keratoderma with scleroatrophy of the extremities |
| RS1560544979 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1560545883 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Hurler syndrome |
| RS1560546604 |
CFI
|
Health Risk |
Likely pathogenic/Likely pathogenic, low penetrance |
CFI-related disorder, CFI-related disorder |
| RS1560546897 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1560556892 |
GRID2
|
Health Risk |
Likely pathogenic |
— |
| RS1560557536 |
WDR19
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS1560558455 |
ODAPH
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta hypomaturation type 2A4, ODAPH-related disorder |
| RS1560562630 |
ODAPH
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A4, Amelogenesis imperfecta hypomaturation type 2A4 |
| RS1560562738 |
ODAPH
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A4, Amelogenesis imperfecta hypomaturation type 2A4 |
| RS1560567337 |
PPP3CA
|
Health Risk |
Pathogenic |
Arthrogryposis, cleft palate |
| RS1560567347 |
PPP3CA
|
Health Risk |
Pathogenic |
Arthrogryposis, cleft palate |